Brian C. Stephenson, Secretary, Treasurer & CFO at BridgeBio Pharma, Inc. (BBIO), sold 67,677 shares at $28.59 ($2.0M) on 2023-08-17, disclosed to the SEC on 2023-08-18.
Scheduled sale ($2.0M) by Secretary, Treasurer & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.80 | 22,311 | $665K | 33.9% |
| 2 | $28.59 | 22,683 | $649K | 33.1% |
| 3 | $28.59 | 22,683 | $649K | 33.1% |
| Total | $28.99 avg | 67,677 | $2.0M | 100% |
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |